Montisci Andrea, Micheletto Giancarlo, Sibilio Serena, Donatelli Francesco, Tespili Maurizio, Banfi Carlo, Casilli Francesco, Cosseta Daniele, Miceli Antonio, Cirri Silvia, Pappalardo Federico
Department of Anesthesia and Intensive Care, Cardiothoracic Centre, Istituto Clinico Sant'Ambrogio, Milan, Italy.
Chair of Cardiac Surgery, Postgraduate in Cardiac Surgery, University of Milan, Milan, Italy.
ESC Heart Fail. 2021 Feb;8(1):167-170. doi: 10.1002/ehf2.12758. Epub 2020 Nov 7.
We describe the case of a 58-year-old man presenting with myocardial infarction complicated by cardiogenic shock, treated with Impella CP which was escalated to an axillary 5.0 due to lack of cardiac recovery. Weaning from Impella 5.0 failed, and the patient was evaluated for heart transplantation (HTx) or left ventricular assist device (LVAD). HTx was excluded because of a rectal adenocarcinoma. The patient underwent colorectal surgery while on Impella. Perioperative course was uneventful. After 61 days of Impella, when the LVAD implantation was scheduled, the patient died due to K. pneumoniae infection.
我们描述了一名58岁男性患者的病例,该患者因心肌梗死并发心源性休克,接受了Impella CP治疗,由于心脏功能未恢复,升级为腋动脉5.0型号。停用Impella 5.0失败,对该患者进行了心脏移植(HTx)或左心室辅助装置(LVAD)评估。由于直肠腺癌,排除了心脏移植。患者在使用Impella期间接受了结直肠手术。围手术期过程顺利。在使用Impella 61天后,计划进行LVAD植入时,患者因肺炎克雷伯菌感染死亡。